{
    "Trade/Device Name(s)": [
        "BD Phoenix\u2122M Automated Microbiology System - Minocycline (1-32 \u03bcg/mL)",
        "BD Phoenix\u2122Automated Microbiology System Minocycline (1-32 \u03bcg/mL) - Gram-Negative ID/AST or AST only",
        "BD PhoenixTM Automated Microbiology System for use with the antimicrobial agent Minocycline (1-32 ug/mL) - Gram-negative ID/AST or AST only Phoenix panels"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K063486",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020321",
        "K060324",
        "K020323",
        "K020322"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "March 7, 2007",
    "Summary Letter Received Date": "November 17, 2006",
    "Submission Date": "November 15, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Minocycline"
    ],
    "Specimen Type(s)": [
        "Isolates from pure culture of Gram-negative bacteria",
        "Isolates from pure culture of Gram-positive bacteria"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix Automated Microbiology System"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution",
        "Automated susceptibility testing",
        "Redox indicator growth detection"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing (AST)",
        "Minimum inhibitory concentration (MIC) determination"
    ],
    "Submission Type(s)": [
        "System",
        "Reagent",
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System panels with Minocycline for automated antimicrobial susceptibility testing of Gram-negative and Gram-positive bacteria.",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by MIC for most Gram-negative aerobic and facultative anaerobic bacteria (including Enterobacteriaceae and Non-Enterobacteriaceae) and most Gram-positive bacteria (Staphylococcus, Enterococcus, Streptococcus) using Minocycline on BD Phoenix panels.",
    "fda_folder": "Microbiology"
}